P0ABE7 (C562_ECOLX) Escherichia coli

Soluble cytochrome b562 UniProtKBInterProSTRINGInteractive Modelling

128 aa; Sequence (Fasta) ; 23 identical sequences

Available Structures

289 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human histamine receptor H3R in complex with antagonist PF03654746 Heteromer
Q9Y5N1;
23-128
1IB;CLR;
Assess
XFEL crystal structure of human melatonin receptor MT2 in complex with 2-phenylmelatonin Heteromer
P00268; P49286;
23-128
JEY;ZN;OLC;
Assess
Structural Insights into the Extracellular Recognition of the Human Serotonin 2B Receptor by an Ant… Heteromer
P41595;
23-128
ERM;
Assess
Crystal structure of 5-HT1B-BRIL and SRP2070_Fab complex Heteromer
P28222;
23-128
ERM;
Assess
Complex structure of angiotensin II type 2 receptor with Fab Heteromer
P01019; P50052;
23-128
Assess
Crystal structure of AT2R-BRIL and SRP2070_Fab complex Heteromer
P01019; P50052;
23-128
Assess
SARS-CoV-2 fusion peptide epitope scaffold FP15 bound to DH1058 Heteromer
23-127
Assess
Human dopamine D2 receptor in complex with spiperone Heteromer
P14416;
24-128
SIP;
Assess
Complex structure of Ghrelin receptor with Fab Heteromer
Q92847;
24-128
8QX;
Assess
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in ternary compl… Heteromer
P55085;
23-127
Assess
Structure of human Frizzled5 by fiducial-assisted cryo-EM Heteromer
Q13467;
23-127
Assess
The BRIL-SLC19A1/Fab/Nb ternary complex Heteromer
P41440;
23-127
Assess
The 5-MTHF-bound BRIL-SLC19A1/Fab/Nb ternary complex Heteromer
P41440;
23-127
THH;
Assess
The TPP-bound BRIL-SLC19A1/Fab/Nb ternary complex Heteromer
P41440;
23-127
TPP;
Assess
FZD3 in inactive state Heteromer
Q9NPG1;
23-127
Assess
FZD6 in inactive state Heteromer
O60353;
23-127
Assess
Cryo-EM structure of inactive FZD1 Heteromer
Q9UP38;
23-127
Assess
Crystal structure of BRIL and SRP2070_Fab complex Heteromer
24-127
Assess
Crystal structure of BRIL in complex with 1b3 Fab Heteromer
24-127
Assess
Structure of the N/OFQ Opioid Receptor in Complex with a Peptide Mimetic Heteromer
P41146;
25-128
0NN;OLB;OLA;OLC;
Assess
Molecular mechanism of biased signaling at the kappa opioid receptor Heteromer
P41145;
24-127
IVB;
Assess
Cryo-EM Structure of GPR61- Heteromer
Q9BZJ8;
24-127
ZOB;
Assess
Crystal structure of BRIL bound to an affinity matured synthetic antibody. Heteromer
23-125
GOL;FMT;NA;
Assess
HMGCR-UBIAD1 Complex State 1 Heteromer
G3IEF0; P00347;
25-127
Y01;AJP;
Assess
HMGCR-UBIAD1 Complex State 2 Heteromer
G3IEF0; P00347;
25-127
Y01;AJP;
Assess
CryoEM structure of human alpha4beta2 nicotinic acetylcholine receptor with varenicline in complex … Heteromer
P17787; P43681;
23-123
NAG;NAG;NAG;QMR;BMA;
Assess
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026 Heteromer
P30556;
24-122
NAG;OLC;CLR;
Assess
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV023 Heteromer
P30556;
24-122
OLC;CLR;
Assess
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II Heteromer
P01019; P30556;
24-122
NAG;CL;
Assess
Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8 Heteromer
P30556;
24-122
NAG;CL;OLC;
Assess
Angiotensin II type 2 receptor with ligand Heteromer
P01019; P50052;
30-115
Assess
Get3 bound to ADP and the transmembrane domain of the tail-anchored protein Bos1 Heteromer
A8B3G9; P25385;
125-127
ADP;ZN;MG;
Assess
Crystal structure of Hat1-Hat2-Asf1-H3-H4 Heteromer
P02309; P39984; P61830; Q12341; Q4WXX5;
126-127
COA;
Assess
Crystal Structure of a nanobody-stabilized active state of the kappa-opioid receptor Heteromer
P41145;
128-128
CVV;CLR;OLA;
Assess
Bimetallic dodecameric cage design 2 (BMC2) from cytochrome cb562homo-12-mer23-128
12×HEC; 24×HAE; 12×FE; 18×ZN;
Assess
Bimetallic dodecameric cage design 3 (BMC3) from cytochrome cb562homo-12-mer23-128
12×HEC; 21×ZN; 12×FE; 24×HAE;1PE;
Assess
A Zn-mediated tetrahedral protein lattice cage encapsulating a microperoxidasehomo-12-mer23-128
15×HEM; 12×ACT; 30×ZN;
Assess
Bimetallic dodecameric cage design 1 (BMC1) from cytochrome cb562homo-12-mer23-128
18×ZN; 12×HAE; 12×HEC;FE;
Assess
A Zn-mediated tetrahedral protein lattice cagehomo-12-mer23-128
12×HEM; 12×ACT; 36×ZN;
Assess
Cryo-EM structure of Bimetallic dodecameric cage design 3 (BMC3) from cytochrome cb562homo-12-mer23-128
12×HEC; 24×HAE; 24×ZN;FE;
Assess
Crystallographic octamer of a metal-free RIDC1 variant bearing two disulfide bonded cysteineshomo-8-mer23-128
HEC; 14×CA;
Assess
Bimetallic hexameric cage design 4 (BMC4) from cytochrome cb562homo-6-mer23-128
HEC; 18×ZN;FE;HAE;
Assess
Crystal structure of an engineered Zn-RIDC1 construct with four interfacial disulfide bondshomo-4-mer23-128
HEM;ZN;SO4;
Assess
Crystal structure of a Zn-bound RIDC1 variant in the presence of reductanthomo-4-mer23-128
ZN;CA;HEC;
Assess
Crystal structure of a Zn-bound RIDC1 varianthomo-4-mer23-128
ZN;HEC;MPD;MRD;EPE;
Assess
Crystal Structure of a Dimeric Cytochrome cb562 Assembly Induced by Copper Coordinationhomo-4-mer23-128
CU;CA;HEM;
Assess
Tetrameric Cytochrome cb562 (K34/H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc …homo-4-mer23-128
ZN;CA;HEM;
Assess
Disulfide-free, Zn-directed tetramer of the engineered cyt cb562 variant, C96T/A104AB3homo-4-mer23-128
HEM;ZN;CL;MG;
Assess
Tetrameric Cytochrome cb562 (H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coor…homo-4-mer23-128
ZN;CA;HEM;
Assess
Crystal structure of the Zn-directed tetramer of the engineered cyt cb562 variant, C96T/AB5homo-4-mer23-128
HEC; 14×ZN;CL;
Assess
Crystal structure of the Zn-induced tetramer of the engineered cyt cb562 variant RIDC-2homo-4-mer23-128
HEM;ZN;
Assess
Crystal structure of a Co-bound RIDC1 varianthomo-4-mer23-128
HEC;CO;
Assess
Crystal structure of an engineered metal-free tetrameric cytochrome cb562 complex templated by Zn-c…homo-4-mer23-128
HEM;
Assess
Crystal structure of the Zn-RIDC1 complex bearing six interfacial disulfide bondshomo-4-mer23-128
HEC;P6G;ZN;
Assess
A tetrameric Zn-bound cytochrome cb562 complex with covalently and non-covalently stabilized interf…homo-4-mer23-128
HEM;ZN;
Assess
Crystal structure of an engineered metal-free RIDC1 construct with four interfacial disulfide bondshomo-4-mer23-128
HEM;
Assess
Crystal structure of a metal-free RIDC1 varianthomo-4-mer23-128
HEC;
Assess
Crystallogrpahic tetramer of Zn-bound RIDC1 variant bearing two disulfide bonded cysteineshomo-4-mer23-128
HEC;CA; 10×ZN;
Assess
Crystal structure of an engineered RIDC1 tetramer with four interfacial disulfide bonds and four th…homo-4-mer23-128
HEM;ZN;
Assess
Crystal structure of a tetrameric Zn-bound cytochrome cb562 complex with covalently and non-covalen…homo-4-mer23-128
HEM;ZN;
Assess
Crystal structure of the Zn-induced tetramer of the engineered cyt cb562 variant RIDC-1homo-4-mer23-128
HEM;ZN;
Assess
Crystal structure of an engineered metal-free RIDC1 variant containing five disulfide bonds.homo-4-mer23-128
HEC;NA;
Assess
Crystal structure of an engineered protein that forms nanotubes with tunable diametershomo-4-mer23-128
HEM; 14×ZN;
Assess
Crystal Structure of the Zn-directed tetramer of the engineered cyt cb562 variant, AB3homo-4-mer23-128
HEC;ZN;
Assess
Crystal structure of the Zn-directed tetramer of the engineered cyt cb562 variant, AB5homo-4-mer23-128
HEC;ZN; 12×CL;
Assess
Crystal structure of a Cu-bound cytochrome cb562 variant in the presence of reductanthomo-4-mer23-128
HEC;CU;
Assess
Crystal structure of the Zn-directed tetramer of the engineered cyt cb562 variant, A104/57G AB3homo-4-mer23-128
HEC; 20×CA;ZN;
Assess
Crystal Structure of a 16-Helix Bundle Architecture Produced by the Zinc-Mediated Self Assembly of …homo-4-mer23-128
HEM;ZN;
Assess
Fe-bound structure of an engineered metal-dependent protein trimer, TriCyt2homo-3-mer23-128
HEC;FE2;SO4;
Assess
Crystallographic trimer of metal-free TriCyt2homo-3-mer23-128
HEC;MPD;SO4;
Assess
Crystal structure of Ni-bound RIDC1 variant in the presence of reductanthomo-3-mer23-128
NI;TRS;HEC;CL;
Assess
Cu-bound structure of the engineered protein trimer, TriCyt3homo-3-mer23-128
HEC;CL;CU;PEG;
Assess
Co-bound structure of an engineered protein trimer, TriCyt3, with delta isomerism at the hexahistid…homo-3-mer23-128
HEC;CO;CL;MG;
Assess
Mn-bound structure of an engineered protein trimer, TriCyt3homo-3-mer23-128
HEC;CA;MN;CL;
Assess
Co-bound structure of an engineered protein trimer, TriCyt3homo-3-mer23-128
HEC;CO;CL;
Assess
Crystal Structure of a Trimeric Cytochrome cb562 Assembly Induced by Nickel Coordinationhomo-3-mer23-128
NI;HEM;
Assess
Ni-bound structure of an engineered protein trimer, TriCyt3homo-3-mer23-128
HEC;NI; 12×CA;CL;
Assess
Crystal structure of a Fe-bound RIDC1 variant in the presence of reductanthomo-3-mer23-128
HEC;FE;1PE;
Assess
Mn-bound structure of a TriCyt3 varianthomo-3-mer23-128
HEC;MN;CL;CA;
Assess
A Triangular Cytochrome b562 Superstructure Mediated by Ni Coordination - Monoclinic Formhomo-3-mer23-128
HEM;PXX;NI;
Assess
Ni-bound structure of an engineered metal-dependent protein trimer, TriCyt1homo-3-mer23-128
HEC;NI;NA;CL;MPD;
Assess
Cu-bound structure of an engineered metal-dependent protein trimer, TriCyt1homo-3-mer23-128
HEC;CU; 15×CA;
Assess
A Zn-mediated asymmetric trimer of a cytochrome cb562 variant (D74A-RIDC1)homo-3-mer23-128
HEM;ZN;
Assess
Crystal structure of the high-affinity copper transporter Ctr1homo-3-mer23-128
TBR;ZN;
Assess
Crystal structure of the high-affinity copper transporter Ctr1 in complex with Cu(I)homo-3-mer23-127
CU1;ZN;
Assess
Cu-bound crystal structure of the engineered cyt cb562 variant, DiCyt2 - H63A, crystallized in the …homo-2-mer23-128
HEC;CA;CU;
Assess
Co-bound crystal structure of the engineered cyt cb562 variant, DiCyt2homo-2-mer23-128
HEC;CO;
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;NI;
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2 - H63A, crystallized in the …homo-2-mer23-128
HEC;NI;
Assess
Zn(II)-bound B2 dimer (H60/H100/H104) formed in Zn(II)//Cu(II) (M1 // M2) conditionhomo-2-mer23-128
HEC;ZN;
Assess
Cu-bound crystal structure of the engineered cyt cb562 variant, DiCyt2 - H63A, crystallized in the …homo-2-mer23-128
HEC;NI;
Assess
Zn(II)-bound B2 dimer (H60/H100/H104) formed in Cu(II)//Zn(II) (M1 // M2) conditionhomo-2-mer23-128
HEC;ZN;
Assess
Heme-Free Cytochrome Variant ApoCythomo-2-mer23-128
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;NI;
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;NI;
Assess
Zn(II)-bound B2 dimer (H60/H100/H104)homo-2-mer23-128
HEC;ZN;
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;CO;
Assess
Ni-bound crystal structure of the engineered cyt cb562 variant, AB2-H100A, crystallized in the pres…homo-2-mer23-128
HEC;NI;
Assess
Domain-swapped cytochrome cb562 dimerhomo-2-mer23-128
HEC;ZN;SO4;
Assess
Ni(II)-bound B2 dimer (H60/H100/H104)homo-2-mer23-128
HEC;NI;MPD;
Assess
Co-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;CO;
Assess
Cu-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in the presenc…homo-2-mer23-128
HEC;CA;CU;
Assess
Co-bound crystal structure of the engineered cyt cb562 variant, AB2-H100A, crystallized in the pres…homo-2-mer23-128
HEC;CO;
Assess
Cu-bound crystal structure of the engineered cyt cb562 variant, DiCyt2 - H97A, crystallized in the …homo-2-mer23-128
HEC;CA;CU;
Assess
Crystal structure of an engineered cytochrome cb562 that forms 1D, Zn-mediated coordination polymershomo-2-mer23-128
HEM;ZN;CA;
Assess
Crystal structure of the dimeric assembly of the cyt cb562 variant RIDC-1homo-2-mer23-128
HEM;
Assess
Crystal structure of the Cu-induced dimer of the engineered cyt cb562 variant RIDC-1homo-2-mer23-128
HEM;CU;CL;
Assess
Crystal structure of an engineered cytochrome cb562 that forms 2D, Zn-mediated sheetshomo-2-mer23-128
HEM;ZN;
Assess
Crystal Structure of a Ni-directed Dimer of Cytochrome cb562 with a Quinolate-Histidine Hybrid Coor…homo-2-mer23-128
HEM;HQI;NI;
Assess
Apo B2 dimer (H60/H100/H104) formed in the presence of Cu(II)homo-2-mer23-128
HEC;SO4;
Assess
Structure of the human smoothened receptor in complex with SAG1.5homo-2-mer23-128
SG8;
Assess
A Multi-generation Analysis of Cytochrome b562 Redox Variants: Evolutionary Strategies for Modulati…homo-2-mer23-128
MG;HEM;
Assess
XFEL structure of human angiotensin II type 2 receptor (Monoclinic form) in complex with compound 1…homo-2-mer23-128
8ES;
Assess
Structure of the human smoothened receptor in complex with SANT-1.homo-2-mer23-128
NAG;SNT;ZN;OLC;PEG;PG4;
Assess
Crystal structure of the chimeric protein of 5-HT1B-BRIL in complex with dihydroergotamine (PSI Com…homo-2-mer23-128
2GM;
Assess
Synchrotron structure of human angiotensin II type 2 receptor in complex with compound 2 (N-[(furan…homo-2-mer23-128
8EM;
Assess
Crystal Structure of a receptor in Complex with inverse agonisthomo-2-mer23-128
OLC;1KQ;
Assess
Crystal structure of the non-ribose partial agonist LUF5833 bound to the adenosine A2A receptorhomo-2-mer23-128
RVZ;OLA;CLR;NA;
Assess
Structure of the human smoothened 7TM receptor in complex with an antitumor agenthomo-2-mer23-127
1KS;OLC;OLA;PEG;PGE;PG4;
Assess
Human class C G protein-coupled metabotropic glutamate receptor 1 in complex with a negative allost…homo-2-mer24-128
FM9;CLR;OLA;OLC;PO4;
Assess
Crystal structure of the human prostaglandin E receptor EP3 bound to prostaglandin E2homo-2-mer23-127
P2E;POV;
Assess
Crystal structure of the human adenosine A1 receptor A1AR-bRIL in complex with the covalent antagon…homo-2-mer23-127
DU1;OLA;
Assess
Crystal structure of dopamine receptor D4 bound to the subtype-selective ligand, L745870homo-2-mer24-127
L74;
Assess
Adenosine A2a receptor mutant-I92Nhomo-2-mer23-123
UKA;
Assess
Human Consensus Olfactory Receptor OR52c in apo state, OR52c-bRILmonomer4-127
Assess
Crystal structure of Xenopus Smoothened in complex with cyclopaminemonomer15-127
CY8;
Assess
Crystal structure of Xenopus Smoothened in complex with cholesterolmonomer15-127
CLR;
Assess
Cu(II)-bound structure of the engineered cyt cb562 variant, CH3Ymonomer23-128
HEC;CU;
Assess
Crystal Structure of B562RIL with engineered disulfide bond T9C-A36Cmonomer23-128
Assess
Co(II)-bound structure of the engineered cyt cb562 variant, CH3monomer23-128
CO;HEC;
Assess
Crystal Structure of B562RIL with engineered disulfide bond K27C-A79Cmonomer23-128
Assess
IMPROVEMENT OF THE 2.5 ANGSTROMS RESOLUTION MODEL OF CYTOCHROME B562 BY REDETERMINING THE PRIMARY S…monomer23-128
SO4;HEM;
Assess
Fe(II)-bound structure of the engineered cyt cb562 variant, CH3Ymonomer23-128
HEC;FE;
Assess
Crystal Structure of B562RIL without disulfide bondmonomer23-128
Assess
Vanadyl-bound structure of the engineered cyt b562 variant, CH3Y*monomer23-128
V;
Assess
Crystal Structure of B562RIL with engineered disulfide bond V16C-A29Cmonomer23-128
SO4;
Assess
Cu(II)-bound structure of the engineered cyt cb562 variant, CH3monomer23-128
CA;HEC;
Assess
Mn(II)-bound structure of the engineered cyt cb562 variant, CH2Emonomer23-128
MN;HEC;
Assess
A2AR crystallized in EROCOC17+4, LCP-SFX at 277 Kmonomer23-128
ZMA;NA;CLR;D12;MYS;HEX;8K6;D10;OCT;UND;ER0;TRD;
Assess
Crystal structure of the chimeric protein of A2aAR-BRIL in complex with ZM241385 at 1.8A resolutionmonomer23-128
ZMA;NA;CLR; 16×OLA;OLC;OLB;PEG;
Assess
A2AR crystallized in EROCOC17+4, LCP-SFX at 293 Kmonomer23-128
ZMA;NA;CLR;D12;MYS;HEX;8K6;D10;OCT;UND;ER0;TRD;
Assess
CRYSTAL STRUCTURE OF B562RIL, A REDESIGNED FOUR HELIX BUNDLEmonomer23-128
SO4;
Assess
Vanadyl-bound structure of the engineered cyt cb562 variant, CH3Ymonomer23-128
V;HEC;
Assess
XFEL A2aR structure by ligand exchange from LUF5843 to ZM241385.monomer23-128
ZMA;OLC;CLR;OLB; 13×OLA;NA;
Assess
Mn(II)-bound structure of the engineered cyt cb562 variant, CH2EYmonomer23-128
HEC;
Assess
Fe(II)-bound structure of the engineered cyt cb562 variant, CH2Emonomer23-128
FE;HEC;
Assess
1.9 angstrom A2a adenosine receptor structure with sulfur SAD phasing and phase extension using XFE…monomer23-128
ZMA;NA;CLR; 10×OLC; 11×OLA;PEG;
Assess
1.9A angstrom A2a adenosine receptor structure with MR phasing using XFEL datamonomer23-128
ZMA;NA;CLR;OLB;OLC; 11×OLA;PEG;
Assess
Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 1.9A obtained from bespoke co-crystallisa…monomer23-128
T4E;CLR; 15×OLA; 11×OLC;TAR;PGE;NA;
Assess
Iron- and Nitric Oxide-bound structure of the engineered cyt b562 variant, CH3Y*monomer23-128
Assess
Iron-bound structure of the engineered cyt b562 variant, CH3Y*monomer23-128
FE;
Assess
Co(II)-bound structure of the engineered cyt cb562 variant, H3monomer23-128
CO;HEC;CL;CA;
Assess
Structure of the A2A-StaR2-bRIL562-LUAA47070 complex at 2.0A obtained from in meso soaking experime…monomer23-128
9Y2;NA;CLR; 13×OLA; 10×OLC;
Assess
A2AR crystallized in EROCOC17+4, SS-ROX at 100 Kmonomer23-128
ZMA;NA;CLR;D12;MYS;HEX;8K6;D10;OCT;UND;ER0;TRD;
Assess
Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 1.86A obtained from in meso soaking exper…monomer23-128
T4E;NA;CLR; 16×OLA; 11×OLC;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with theophylline…monomer23-128
NA;TEP;CLR; 22×OLA;OLC;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12f…monomer23-128
NA;6DZ;HTO;CLR; 19×OLA;OLB;OLC;
Assess
Crystal structure of the phenanthroline-modified cytochrome cb562 variant, MBP-Phen2monomer23-128
HEM;PXX;ACT;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with caffeine at …monomer23-128
NA;CFF;CLR; 18×OLA;OLC;TAR;
Assess
Structure of the A2A-StaR2-bRIL562-Compound 4e complex at 2.1A obtained from in meso soaking experi…monomer23-128
T4E;NA; 14×OLA;CLR; 12×OLC;CL;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with clinical can…monomer23-128
NA;U30;CLR; 15×OLA;OLB;OLC;
Assess
Crystal structure of the adenosine A2A receptor (construct A2A-PSB2-bRIL) complexed with Etrumadena…monomer23-128
U30;CLR;OLA;OLC;OLB;PEG;
Assess
Crystal Structure of B562RIL with engineered disulfide bond A20C-Q25Cmonomer23-128
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12b…monomer23-128
NA;6DX;CLR; 17×OLA;OLB;
Assess
XFEL crystal structure of the human sphingosine 1 phosphate receptor 5 in complex with ONO-5430608monomer23-128
NAG;B2O;OLC;
Assess
Crystal structure of E. coli cytochrome b562 with engineered c-type heme linkagesmonomer23-128
SO4;HEC;
Assess
Crystal structure of the adenosine A2A receptor (A2A-PSB1-bRIL) in complex with preladenant conjuga…monomer23-128
CLR;8E2; 26×OLA;OLC;PEG;
Assess
Fe(II)-bound structure of the engineered cyt cb562 variant, CH3monomer23-128
FE;HEC;CA;
Assess
Structure of human A2A adenosine receptor in complex with ZM241385 obtained from SFX experiments un…monomer23-128
NA;ZMA; 19×OLA;CLR;
Assess
Crystal structure of human adenosine A2A receptor in complex with an insurmountable inverse agonist…monomer23-128
JQR;CLR; 18×OLC;PE4;NA;
Assess
2.35-Angstrom In situ Mylar structure of human A2A adenosine receptor at 100 Kmonomer23-128
ZMA;NA;CLR;OLC; 10×OLA;OLB;
Assess
Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2570366 (F222 s…monomer23-128
KNW;CLR;OLC; 21×OLA;PGE;
Assess
Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2570366 (C2221 …monomer23-128
KNW;CLR;TLA; 16×OLC; 10×OLA;1PE;
Assess
Crystal structure of A2AAR-StaR2-bRIL in complex with compound 21amonomer23-128
TKO;CLR;OLC; 17×OLA;
Assess
Crystal structure of P2Y12 receptor in complex with 2MeSADPmonomer23-128
6AD;CLR;OLC;PEG;
Assess
2.5 angstrom A2a adenosine receptor structure with sulfur SAD phasing using XFEL datamonomer23-128
ZMA;NA;CLR; 10×OLC; 10×OLA;PEG;
Assess
2.5 angstrom A2a adenosine receptor structure with MR phasing using XFEL datamonomer23-128
ZMA;NA;CLR;OLB;OLC;OLA;
Assess
Crystal structure of the human thromboxane A2 receptor bound to ramatrobanmonomer23-128
A8X;ZN;CLR;OLC;GOL;
Assess
Crystal structure of A2AAR-BRIL in complex with the antagonist ZM241385 produced from Pichia pastor…monomer23-128
ZMA;CLR;OLB;OLA;OLC;
Assess
XFEL crystal structure of the human cysteinyl leukotriene receptor 1 in complex with zafirlukastmonomer22-127
ZLK;OLC; 11×OLA;1PE;NA;
Assess
Structure of the A2A-StaR2-bRIL562-Vipadenant complex at 2.6A obtained from in meso soaking experim…monomer23-128
9XT; 15×OLA;NA;CLR;OLC;
Assess
Crystal structure of the adenosine A2A receptor (A2A-PSB1-bRIL) in complex with preladenant conjuga…monomer23-128
CLR;8IM; 25×OLA;OLC;PEG;
Assess
Structure of the human smoothened receptor in complex with ANTA XVmonomer23-128
A8T;ZN;
Assess
Structure of the human P2Y12 receptor in complex with an antithrombotic drugmonomer23-128
AZJ;CLR;OLC;
Assess
Crystal structure of human GPCR Niacin receptor (HCA2)monomer23-128
OLA;OLC;PEG;UNX;
Assess
Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2080365monomer23-128
KNZ; 10×OLC;OLA;
Assess
Crystal structure of cysteinyl leukotriene receptor 1 in complex with pranlukastmonomer22-127
KNT;NA;OLC;OLA;
Assess
XFEL structure of the human delta opioid receptor in complex with a bifunctional peptidemonomer23-128
OLA;NA;OLC;
Assess
Crystal structure of the chimeric protein of 5-HT2B-BRIL in complex with ergotaminemonomer23-128
ERM;PLM;CLR;OLC;OLB;OLA;PEG;
Assess
Crystal structure of 5-HT2C in complex with ritanserinmonomer23-128
E2J;OLC;PEG;OLA;
Assess
Crystal structure of the chimeric protein of 5-HT1B-BRIL in complex with ergotamine (PSI Community …monomer23-128
ERM;OLB;
Assess
Crystal structure of 5-HT2AR in complex with (R)-IHCH-7179monomer23-128
MG;EZX;OLC;CLR;1PE;PEG;
Assess
Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2770372monomer23-128
KO5;CLR;1PE; 13×OLC;OLA;
Assess
Metal-free structure of the engineered cyt cb562 variant, CH3monomer23-128
HEC;CA;
Assess
Cytochrome b562 integral fusion with EGFPmonomer23-128
HEM;
Assess
Crystal structure of the P2Y12 receptor in complex with the inverse agonist selatogrel.monomer23-128
7Y5;CLR;
Assess
Crystal structure of the chimeric protein of A2aAR-BRIL with bound iodide ionsmonomer23-128
ZMA;CLR;IOD;PEG;OLA;OLC;OLB;
Assess
XFEL structure of human angiotensin II type 2 receptor (Orthorhombic form) in complex with compound…monomer23-128
8ES;OLC;OLA;
Assess
Crystal structure of the human formyl peptide receptor 2 in complex with WKYMVmmonomer23-128
CLR;
Assess
Crystal structure of a zinc mediated dimer for the phenanthroline-modified cytochrome cb562 variant…monomer23-128
HEM;PXX;
Assess
Crystal structure of the 5-HT2B receptor solved using serial femtosecond crystallography in lipidic…monomer23-128
PLM;ERM;CLR;OLC;PEG;TRS;OLA;DGA;
Assess
Crystal structure of 5-HT2AR in complex with zotepinemonomer23-128
ZOT;CLR;1PE;ZN;
Assess
Crystal structure of 5-HT2AR in complex with aripiprazolemonomer23-128
CLR;1PE;OLC;9SC;MG;
Assess
Crystal structure of the LSD-bound 5-HT2B receptormonomer23-128
7LD;CLR;OLC;PEG;PO4;
Assess
Crystal structure of 5-HT2C in complex with ergotaminemonomer23-128
ERM;OLC;
Assess
A Triangular Cytochrome b562 Superstructure Mediated by Ni Coordination - Hexagonal Formmonomer23-128
HEM;PXX;NI;
Assess
Crystal structure of the angiotensin II type 2 receptoror (AT2R) in complex with EMA401monomer23-128
VFD;OLC;OLA;FMT;HEZ;
Assess
Crystal structure of the human thromboxane A2 receptor bound to daltrobanmonomer23-128
A90;ZN;CLR;GOL;
Assess
Crystal structure of 5-HT2AR in complex with risperidonemonomer23-128
8NU;CLR;ZN;1PE;
Assess
XFEL crystal structure of human melatonin receptor MT2 (N86D) in complex with 2-phenylmelatoninmonomer23-128
JEY;ZN;
Assess
Crystal structure of a nickel mediated dimer for the phenanthroline-modified cytochrome cb562 varia…monomer23-128
HEM;PXX;
Assess
Crystal structure of P2Y12 receptor in complex with 2MeSATPmonomer23-128
6AT;OLC;
Assess
Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptormonomer23-128
CLR;OLC;PEG;H8M;
Assess
Serial Millisecond Crystallography of Membrane and Soluble Protein Micro-crystals using Synchrotron…monomer23-128
ZMA;CLR;OLC;OLA;
Assess
XFEL crystal structure of human melatonin receptor MT2 (H208A) in complex with 2-phenylmelatoninmonomer23-128
JEY;ZN;
Assess
Human Smoothened Receptor structure in complex with cyclopaminemonomer23-128
CY8;
Assess
XFEL crystal structure of human melatonin receptor MT2 in complex with ramelteonmonomer23-128
JEV;ZN;
Assess
Structure of the class B human glucagon G protein coupled receptormonomer23-128
PEG;
Assess
Crystal structure of 5-HT2AR in complex with cariprazinemonomer23-128
MG;CLR;OLC;7RU;
Assess
Crystal structure of HTR2A with hallucinogenic agonistmonomer23-128
7LD;CLR;OLA;PEG;
Assess
Crystal structure of HTR2A with inverse agonistmonomer23-128
89F;OLA;CLR;PEG;
Assess
Room-temperature structure of the stabilised A2A-Theophylline complex determined by synchrotron ser…monomer23-128
TEP;CLR;OLA;OLC;NA;
Assess
Room-temperature structure of the stabilised A2A-LUAA47070 complex determined by synchrotron serial…monomer23-128
9Y2;CLR;OLA;NA;
Assess
Crystal structure of adenosine A2A receptor bound to a novel triazole-carboximidamide antagonistmonomer23-128
EDT;MES;8D1;
Assess
SOLUTION STRUCTURE OF OXIDIZED ESCHERICHIA COLI CYTOCHROME B562monomer23-128
HEM;
Assess
SOLUTION STRUCTURE OF APOCYTOCHROME B562monomer23-128
Assess
CryoEM structure of the adenosine 2A receptor-BRIL/Anti BRIL Fab complex with ZM241385monomer23-128
ZMA;
Assess
THE SOLUTION STRUCTURE OF THE HEME BINDING VARIANT ARG98CYS OF OXIDIZED ESCHERICHIA COLI CYTOCHROME…monomer23-128
HEB;
Assess
Cryo-EM structure of the beta2AR-mBRIL/1b3 Fab/Glue complex with a partial agonistmonomer23-128
H98;
Assess
cryo-EM structure of the beta2-AR-mBRIL/1b3 Fab/Glue complex with a full agonistmonomer23-128
DZQ;
Assess
MicroED structure of the human adenosine receptor at 2.8Amonomer23-128
ZMA;CLR;NA;
Assess
A2A Adenosine receptor room-temperature structure determined by serial femtosecond crystallographymonomer23-127
OLA;NA;ZMA;CLR;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with ZM241385 at …monomer23-127
NA;ZMA;CLR; 20×OLA;OLB;OLC;
Assess
1.8 A Structure of the human delta opioid 7TM receptor (PSI Community Target)monomer24-128
12×OLA;OLC;PGE;TLA;EJ4;NA;
Assess
Structure of the A2A-StaR2-bRIL562-ZM241385 complex at 1.86A obtained from in meso soaking experime…monomer23-127
ZMA;CLR; 17×OLA;SCN;OLC;CIT;NA;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12c…monomer23-127
NA;6DY;CLR; 18×OLA;OLB;OLC;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with Chromone 4dmonomer23-127
QGE;NA;CLR; 11×OLA;OLC;
Assess
A2A Adenosine receptor cryo structuremonomer23-127
NA;ZMA; 15×OLA;OLB;OLC;CLR;
Assess
Structure of the human D4 Dopamine receptor in complex with Nemonapridemonomer24-128
AQD;PO4;OLA;PEG;GOL;
Assess
2.0A angstrom A2a adenosine receptor structure using XFEL data collected in helium atmosphere.monomer23-127
NA;ZMA;CLR; 15×OLA;OLC;GOL;OLB;
Assess
Crystal Structure of the A2A-StaR2-bRIL562 in complex with AZD4635 at 2.0A resolutionmonomer23-127
NA;F9Q;CLR; 15×OLA; 10×OLC;
Assess
Crystal structure of A2AAR-StaR2-bRIL in complex with a novel A2a antagonist, LJ-4517monomer23-127
PEG;LJX;NA;OLC; 23×OLA;CLR;ETF;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12x…monomer23-127
NA;6DV;CLR; 16×OLA;OLB;OLC;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with Chromone 5dmonomer23-127
QGW;NA;CLR;OLB; 14×OLA;OLC;
Assess
A2A Adenosine receptor room-temperature structure determined by serial millisecond crystallographymonomer23-127
OLA;NA;ZMA;CLR;
Assess
Structure of the sodium-bound human D4 Dopamine receptor in complex with Nemonapridemonomer24-128
AQD;PO4;OLA;PEG;NA;
Assess
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMSmonomer23-127
3C0;
Assess
In meso structure of the adenosine A2a G protein-coupled receptor, A2aR, in 7.10 monoacylglycerolmonomer23-127
ZMA;CLR;A1H2K;A1H52;GOL;NA;
Assess
Crystal structure of serotonin 2A receptor in complex with lumateperonemonomer23-127
MG;CLR;1PE; 11×OLC;92S;PEG;
Assess
Crystal structure of serotonin 2A receptor in complex with non-hallucinogenic psychedelic analogmonomer23-127
MG;CLR;OLC;93F;1PE;PEG;
Assess
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NM…monomer23-127
3C0;HG;
Assess
Crystal structure of serotonin 2A receptor in complex with LSDmonomer23-127
MG;CLR;OLC;7LD;1PE;PEG;
Assess
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with QNBmonomer23-127
QNB;
Assess
Crystal structure of serotonin 2A receptor in complex with lisuridemonomer23-127
MG;CLR;1PE;OLC;PEG;H8G;
Assess
Structure of the A2A adenosine receptor determined at SwissFEL using native-SAD at 4.57 keV from 50…monomer23-127
ZMA;OLA;OLB;OLC;CLR;
Assess
Crystal structure of human alkaline ceramidase 3 (ACER3) at 2.7 Angstrom resolutionmonomer23-127
ZN;SO4;NA;OLB;CA;MG;
Assess
Crystal structure of human GPCR Niacin receptor (HCA2) expressed from Spodoptera frugiperdamonomer23-127
OLA;OLC;
Assess
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with PSB36 at 2.8…monomer23-127
NA;8JN;CLR; 21×OLA;OLC;TAR;
Assess
Crystal Structure of Human Angiotensin Receptor in Complex with Inverse Agonist Olmesartan at 2.8A …monomer24-128
OLM;
Assess
Crystal structure of A2AAR-StaR2-S277-bRIL in complex with a novel A2a antagonist, LJ-4517monomer23-127
16×OLA;OLC;PEG;LJX;CLR;
Assess
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with …monomer23-127
8TZ;NA;PO4;
Assess
Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allo…monomer24-128
9P2;
Assess
Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO-9910539monomer23-127
ON9;1WV;
Assess
Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO-3080573monomer23-127
ON3;1WV;
Assess
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with AF…monomer23-127
82F;
Assess
Structure of human Smoothened in complex with cholesterol and SAGmonomer23-127
V0S;CLR;NAG;NA;MPG;
Assess
Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO9780307monomer23-127
ON7;1WV;
Assess
Crystal structure of M2 muscarinic acetylcholine receptor bound with NMSmonomer23-127
3C0;
Assess
Structure of the A2A-StaR2-bRIL562-Tozadenant complex at 3.1A obtained from in meso soaking experim…monomer23-127
9XW;CLR; 10×OLA;OLC;NA;
Assess
Structure of human Smoothened in complex with cholesterolmonomer23-127
NAG;CLR;NA;
Assess
Synchrotron structure of the human delta opioid receptor in complex with a bifunctional peptide (PS…monomer24-128
OLC;
Assess
Structure of human Smoothened in complex with Vismodegibmonomer23-127
NAG;VIS;
Assess
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with …monomer23-127
8UN;NA;
Assess
High-viscosity injector-based Pink Beam Serial Crystallography of Micro-crystals at a Synchrotron R…monomer23-127
ZMA;
Assess
The solution structure of a redesigned apocytochrome B562 (Rd-apocyt b562) with the N-terminal heli…monomer23-127
Assess
Cryo-EM structure of the beta2AR-mBRIL/1b3 Fab/Glue complex with an antagonistmonomer23-127
JTZ;
Assess
MicroED structure of A2A from plasma milled lamellaemonomer23-127
ZMA;CLR; 15×OLA;OLC;OLB;NA;
Assess
Crystal structure of human C5a receptor in complex with an orthosteric antagonist PMX53 and an allo…monomer25-128
EFD;MLI;NA;PGE;OLC;OLA;
Assess
XFEL structure of human Angiotensin Receptormonomer24-127
ZD7;
Assess
The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with C-35 (PSI Co…monomer25-128
DGV;OLC;OLA;
Assess
The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111 (P…monomer25-128
OLA;DGW;OLC;
Assess
Crystal structure of stabilized A1 receptor in complex with PSB36 at 3.3A resolutionmonomer24-127
8K8;SO4;
Assess
Structure of MurJ from Escherichia colimonomer24-127
PO4;
Assess
The solution structure of a redesigned apocytochrome B562 (Rd-apocyt b562) with the N- and a part o…monomer23-126
Assess
Structure of A2A adenosine receptor A2AR-StaR2-bRIL, solved at wavelength 2.75 Amonomer23-123
TEP; 12×OLA;CLR;
Assess
Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptormonomer23-123
H8D;CLR;OLA;OLC;PEG;PO4;
Assess
Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptormonomer23-123
H8G;CLR;OLC;
Assess
Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptormonomer23-123
CLR;OLA;OLC;PEG;PO4;H8J;
Assess
Human Consensus Olfactory Receptor OR52c in apo state, OR52c onlymonomer4-13
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3u8p.1.Amonomer0.8313-128
91.38
Assess
1yza.1.Amonomer0.5323-128
91.51
Assess